471 related articles for article (PubMed ID: 26989994)
1. An autoimmune bullous dermatosis with clinical, histopathological and immunological features of bullous pemphigoid and epidermolysis bullosa acquisita in an adult.
Yamase A; Kono T; Ishii N; Hashimoto T; Saeki H
Br J Dermatol; 2016 Oct; 175(4):790-3. PubMed ID: 26989994
[No Abstract] [Full Text] [Related]
2. A case of mixed bullous disease of epidermolysis bullosa acquisita and linear IgA bullous dermatosis.
Osawa M; Demitsu T; Toda S; Yokokura H; Umemoto N; Yamada T; Yoneda K; Kakurai M; Yoshida M; Hashimoto T
Dermatology; 2005; 211(2):146-8. PubMed ID: 16088162
[TBL] [Abstract][Full Text] [Related]
3. Autoreactivity to bullous pemphigoid 180: is this the link between subepidermal blistering diseases and oral lichen planus?
Shipman AR; Cooper S; Wojnarowska F
Clin Exp Dermatol; 2011 Apr; 36(3):267-9. PubMed ID: 20569254
[TBL] [Abstract][Full Text] [Related]
4. New immunomodulating drugs in autoimmune blistering diseases.
Korman NJ
Dermatol Clin; 2001 Oct; 19(4):637-48, viii. PubMed ID: 11705351
[TBL] [Abstract][Full Text] [Related]
5. Nutrition and bullous diseases.
Stoj V; Lu J
Clin Dermatol; 2022; 40(2):156-165. PubMed ID: 34808244
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune blistering dermatoses as systemic diseases.
Vassileva S; Drenovska K; Manuelyan K
Clin Dermatol; 2014; 32(3):364-75. PubMed ID: 24767184
[TBL] [Abstract][Full Text] [Related]
7. [Autoimmune bullous skin disorders].
Hertl M; Niedermeier A; Borradori L
Ther Umsch; 2010 Sep; 67(9):465-82. PubMed ID: 20806175
[TBL] [Abstract][Full Text] [Related]
8. Bullous autoimmune dermatoses.
Hofmann SC; Juratli HA; Eming R
J Dtsch Dermatol Ges; 2018 Nov; 16(11):1339-1358. PubMed ID: 30395395
[TBL] [Abstract][Full Text] [Related]
9. Epidermolysis bullosa acquisita localized to the face.
Choi GS; Lee ES; Kim SC; Lee S
J Dermatol; 1998 Jan; 25(1):19-22. PubMed ID: 9519604
[TBL] [Abstract][Full Text] [Related]
10. Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximab.
Wallet-Faber N; Franck N; Batteux F; Mateus C; Gilbert D; Carlotti A; Avril MF; Dupin N
Dermatology; 2007; 215(3):252-5. PubMed ID: 17823525
[TBL] [Abstract][Full Text] [Related]
11. Treatment of subepidermal immunobullous diseases.
Culton DA; Diaz LA
Clin Dermatol; 2012; 30(1):95-102. PubMed ID: 22137232
[TBL] [Abstract][Full Text] [Related]
12. Direct immunofluorescence microscopy of 1 mol/L sodium chloride-treated patient skin.
Domloge-Hultsch N; Bisalbutra P; Gammon WR; Yancey KB
J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):946-51. PubMed ID: 1869682
[TBL] [Abstract][Full Text] [Related]
13. Drug Development in Pemphigoid Diseases.
Bieber K; Ludwig RJ
Acta Derm Venereol; 2020 Feb; 100(5):adv00055. PubMed ID: 32039458
[TBL] [Abstract][Full Text] [Related]
14. Case of concurrent epidermolysis bullosa acquisita and anti-p200 pemphigoid--how to treat it?
Pastar Z; Rados J; Lipozencic J; Dobric I; Marinovic B; Ishii N; Hashimoto T
Int J Dermatol; 2007 Mar; 46(3):295-8. PubMed ID: 17343589
[No Abstract] [Full Text] [Related]
15. Subtle differences in the morphology of bullous lesions between epidermolysis bullosa acquisita and bullous pemphigoid.
Lee CW
J Dermatol; 1992 Jul; 19(7):443-4. PubMed ID: 1401503
[No Abstract] [Full Text] [Related]
16. Blistering diseases in the mature patient.
Lakoš Jukić I; Jerković Gulin S; Marinović B
Clin Dermatol; 2018; 36(2):231-238. PubMed ID: 29566927
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing Epidermolysis Bullosa Acquisita From Bullous Pemphigoid Without Direct Immunofluorescence.
Gardner KM; Crawford RI
J Cutan Med Surg; 2018; 22(1):22-24. PubMed ID: 28719980
[TBL] [Abstract][Full Text] [Related]
18. [Epidermolysis bullosa acquisita].
Hofmann SC; Weidinger A
Hautarzt; 2019 Apr; 70(4):265-270. PubMed ID: 30887080
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune blistering diseases in the elderly.
Parker SR; MacKelfresh J
Clin Dermatol; 2011; 29(1):69-79. PubMed ID: 21146735
[TBL] [Abstract][Full Text] [Related]
20. Treatment of subepidermal immunobullous diseases.
Wojnarowska F; Kirtschig G; Khumalo N
Clin Dermatol; 2001; 19(6):768-77. PubMed ID: 11705687
[No Abstract] [Full Text] [Related]
[Next] [New Search]
